1-804-709-0144
ichip-hi-edit

iCHIP® Platform

ImmunArray’s iCHIP® technology mines the information stored in the immune system repertoires in order to shed light on an individual’s specific immune profile.

Learn More

iCHIP intensity

SLE-key®

SLE-key® is a molecular diagnostic test developed by ImmunArray to support a physician’s ability to rule-out a diagnosis of Systemic Lupus Erythematosus (SLE).

Learn More

TBI-continuum-square

TBI Program

Immunarray® is developing a series of assays and multiplex tests to assist in the diagnosis and prognosis of Brain Injury, in both acute (TBI) and chronic phases.

Learn More

See us at

See Us At

NORM 2016 (National Organization for Rheumatology Managers)

September 16 – September 17, 2016, Mobile, Alabama

Table # 38

Read More
fan

Recent News & Events

ImmunArray Expanding Research and Clinical Momentum on TBI Front

Molecular diagnostic company’s research into blood-based diagnosis of traumatic brain injury presented at national conferences

 Richmond, Va., July 18, 2016 – Clinical research into ways in which blood-based biomarkers can provide precise and timely diagnosis of traumatic brain injury (TBI) is leading to encouraging results, with some studies resulting in a diagnosis with more than 95 percent sensitivity and specificity.

Read More
our-story-crop

Talk to Us

Welcome!

We are a clinically driven company guided by leadership physician input at each stage of our development. We welcome questions and open discussions, and look forward to continuing to work with our collaborators and partners around the globe.

Read More